| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |